share_log
Reuters ·  Mar 26 10:00
IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for Ide275 (GSK959), a Phase 1 Werner Helicase Inhibitor
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 399

Recommended

Write a comment